The magnitude of neurocognitive disorders and associated factors among people living with HIV AIDS facilities in Bahir Dar City Ethiopia

被引:1
作者
Manaye, Meseret [1 ]
Melese, Ergoye [1 ]
Wassie, Gizachew Tadesse [1 ]
机构
[1] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, POB 79, Bahir Dar, Ethiopia
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
HIV AIDS; Infectious diseases; Neurocognitive disorder; Mental health; Bahir Dar; Ethiopia; ANTIRETROVIRAL THERAPY; PREVALENCE; INFECTION; SURVIVAL; IMPAIRMENT; DEPRESSION;
D O I
10.1038/s41598-024-68909-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Neurocognitive disorders are mental health conditions that are caused by medical illnesses and can lead to several acquired cognitive deficits, which represent a decline from a previously attained level of functioning. The principal domains of cognitive functions include complex attention, executive function, learning and memory, language, perceptual-motor function, and social cognition. Studies have shown that people living with human immunodeficiency virus (HIV) are at a heightened risk of experiencing cognitive challenges across multiple domains. Given that, a substantial number of people live in Amhara region, assessing cognitive domains to estimate the current magnitude and factors associated with neurocognitive disorders among HIV/AIDS patients is crucial. An institutional-based cross-sectional study was conducted among 569 participants adults living with HIV attending the city's selected health facilities from March 20 to April 30, 2023. A multistage sampling technique was used. The International HIV Dementia Scale (IHDS) was used to measure the outcome of interest. The data were collected using a structured questionnaire and document review. The data were analyzed using STATA version 14. Multiple binary logistic regressions were used as the final model. A total of 501 individuals, with a response rate of 88.04% participated in the study. The overall proportion of HIV patients with neurocognitive impairment was 54.7% (95% CI 50.62-58.77). Factors associated with the neurocognitive impairment were: being widowed AOR = 3.05 (95% CI 1.47-6.31), divorced AOR = 1.95 (1.16-3.28), rural residence AOR = 2.28 (95% CI 1.02-5.09), CD4 count below 500 cells/dl AOR = 1.61 (95% CI 1.03-2.50), history of opportunistic infection AOR = 2.21 (95% CI 1.42-3.41), being in first-line drug regimen AOR = 2.92 (95% CI 1.22-7.00), being in a first-line regimen with Efavirenz AOR = 4.36 (95% CI 1.07-17.73), and impairment in daily living AOR = 2.64 (95% CI 1.39-4.99). In this study, the proportion of neurocognitive impairment was greater than that in most previous studies conducted in Ethiopia. The factors associated with the disorder were: being widowed or divorced, living in a rural area, having low CD4, having a history of opportunistic infection, receiving a first-line drug regimen, receiving efavirenz-containing drugs, and having impaired daily living. Hence, routine neuropsychological screenings should be integrated into comprehensive ART care by the regional health bureau and implemented by hospitals and health centers.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Dementia and neurocognitive disorders due to HIV-1 infection
    Ances, Beau M.
    Ellis, Ronald J.
    [J]. SEMINARS IN NEUROLOGY, 2007, 27 (01) : 86 - 92
  • [2] High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study
    Animut, Megbaru Debalkie
    Sorrie, Muluken Bekele
    Birhanu, Yinager Workineh
    Teshale, Manaye Yihune
    [J]. PLOS ONE, 2019, 14 (03):
  • [3] [Anonymous], 2016, MoCA Basic administration and scoring instruction
  • [4] Araya T, 2020, ETHIOP J HEALTH DEV, V34
  • [5] Belete T, 2017, ETHIOP J HEALTH SCI, V27, P67, DOI 10.4314/ejhs.v27i1.9
  • [6] Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
    Ciccarelli, N.
    Fabbiani, M.
    Di Giambenedetto, S.
    Fanti, I.
    Baldonero, E.
    Bracciale, L.
    Tamburrini, E.
    Cauda, R.
    De Luca, A.
    Silveri, M. C.
    [J]. NEUROLOGY, 2011, 76 (16) : 1403 - 1409
  • [7] Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?
    Ciccarelli, Nicoletta
    [J]. INFECTION, 2020, 48 (01) : 37 - 42
  • [8] HIV-associated neurocognitive disorder
    Clifford, David B.
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2017, 30 (01) : 117 - 122
  • [9] Psychometric Properties of the Montreal Cognitive Assessment (MoCA) to Detect Major Neurocognitive Disorder Among Older People in Ethiopia: A Validation Study
    Daniel, Beniam
    Agenagnew, Liyew
    Workicho, Abdulhalik
    Abera, Mubarek
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 1789 - 1798
  • [10] Risk factors for symptomaticHIV-associated neurocognitive disorder in adults aged 50 and over attending aHIVclinic in Tanzania
    Eaton, Patrick
    Lewis, Thomas
    Kellett-Wright, Johanna
    Flatt, Aidan
    Urasa, Sarah
    Howlett, William
    Dekker, Marieke
    Kisoli, Aloyce
    Rogathe, Jane
    Thornton, Jessica
    McCartney, Judith
    Yarwood, Vanessa
    Irwin, Charlotte
    Mukaetova-Ladinska, Elizabeta B.
    Akinyemi, Rufus
    Gray, William K.
    Walker, Richard W.
    Dotchin, Catherine L.
    Makupa, Philip C.
    Quaker, Andrew-Leon S.
    Paddick, Stella-Maria
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 35 (10) : 1198 - 1208